Comgest Global Investors S.A.S. Buys 2,159 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Comgest Global Investors S.A.S. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,306 shares of the medical equipment provider’s stock after acquiring an additional 2,159 shares during the quarter. Comgest Global Investors S.A.S.’s holdings in Intuitive Surgical were worth $9,976,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in ISRG. International Assets Investment Management LLC raised its position in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new position in shares of Intuitive Surgical during the first quarter worth about $374,390,000. Strategic Financial Concepts LLC raised its position in shares of Intuitive Surgical by 40,221.4% during the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after acquiring an additional 265,461 shares during the last quarter. GQG Partners LLC bought a new position in shares of Intuitive Surgical during the first quarter worth about $99,523,000. Finally, Canada Pension Plan Investment Board raised its position in shares of Intuitive Surgical by 36.4% during the first quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider’s stock worth $322,377,000 after acquiring an additional 215,444 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ISRG shares. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a report on Thursday, August 22nd. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Piper Sandler reiterated an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Raymond James lifted their target price on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Trading Down 1.9 %

Shares of NASDAQ:ISRG traded down $10.19 during mid-day trading on Friday, hitting $527.61. 1,447,901 shares of the company traded hands, compared to its average volume of 1,461,285. The stock has a market cap of $187.92 billion, a P/E ratio of 84.82, a P/E/G ratio of 5.28 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $295.02 and a 12-month high of $544.38. The stock has a 50-day moving average price of $499.29 and a two-hundred day moving average price of $457.28.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the business’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. The trade was a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,178 shares of company stock valued at $45,897,071. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.